469 related articles for article (PubMed ID: 30458822)
1. Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives.
Poh TY; Ali NABM; Mac Aogáin M; Kathawala MH; Setyawati MI; Ng KW; Chotirmall SH
Part Fibre Toxicol; 2018 Nov; 15(1):46. PubMed ID: 30458822
[TBL] [Abstract][Full Text] [Related]
2. The influence of air pollution on respiratory microbiome: A link to respiratory disease.
Xue Y; Chu J; Li Y; Kong X
Toxicol Lett; 2020 Nov; 334():14-20. PubMed ID: 32949622
[TBL] [Abstract][Full Text] [Related]
3. A combined experimental and numerical study on upper airway dosimetry of inhaled nanoparticles from an electrical discharge machine shop.
Tian L; Shang Y; Chen R; Bai R; Chen C; Inthavong K; Tu J
Part Fibre Toxicol; 2017 Jul; 14(1):24. PubMed ID: 28701167
[TBL] [Abstract][Full Text] [Related]
4. New frontiers in nanotoxicology: Gut microbiota/microbiome-mediated effects of engineered nanomaterials.
Pietroiusti A; Magrini A; Campagnolo L
Toxicol Appl Pharmacol; 2016 May; 299():90-5. PubMed ID: 26723910
[TBL] [Abstract][Full Text] [Related]
5. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.
Warheit DB; Borm PJ; Hennes C; Lademann J
Inhal Toxicol; 2007 Jun; 19(8):631-43. PubMed ID: 17510836
[TBL] [Abstract][Full Text] [Related]
6. The respiratory microbiome: an underappreciated player in the human response to inhaled pollutants?
Adar SD; Huffnagle GB; Curtis JL
Ann Epidemiol; 2016 May; 26(5):355-9. PubMed ID: 27161078
[TBL] [Abstract][Full Text] [Related]
7. [Physio-pathological impacts of inhaled nanoparticles].
Baeza-Squiban A
Biol Aujourdhui; 2014; 208(2):151-8. PubMed ID: 25190574
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles: a review of particle toxicology following inhalation exposure.
Bakand S; Hayes A; Dechsakulthorn F
Inhal Toxicol; 2012; 24(2):125-35. PubMed ID: 22260506
[TBL] [Abstract][Full Text] [Related]
9. Effects of concentrated ambient particles on normal and hypersecretory airways in rats.
Harkema JR; Keeler G; Wagner J; Morishita M; Timm E; Hotchkiss J; Marsik F; Dvonch T; Kaminski N; Barr E
Res Rep Health Eff Inst; 2004 Aug; (120):1-68; discussion 69-79. PubMed ID: 15543855
[TBL] [Abstract][Full Text] [Related]
10. Health effects of inhaled engineered and incidental nanoparticles.
Madl AK; Pinkerton KE
Crit Rev Toxicol; 2009; 39(8):629-58. PubMed ID: 19743943
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease.
Meldrum K; Guo C; Marczylo EL; Gant TW; Smith R; Leonard MO
Part Fibre Toxicol; 2017 Nov; 14(1):45. PubMed ID: 29157272
[TBL] [Abstract][Full Text] [Related]
12. The airway microbiome and disease.
Marsland BJ; Yadava K; Nicod LP
Chest; 2013 Aug; 144(2):632-637. PubMed ID: 23918107
[TBL] [Abstract][Full Text] [Related]
13. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
[TBL] [Abstract][Full Text] [Related]
14. Lung Microbiota and Its Impact on the Mucosal Immune Phenotype.
Wu BG; Segal LN
Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643622
[TBL] [Abstract][Full Text] [Related]
15. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.
Oberdorster G
Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496
[TBL] [Abstract][Full Text] [Related]
16. Biological interactions and toxicity of nanomaterials in the respiratory tract and various approaches of aerosol generation for toxicity testing.
Creutzenberg O
Arch Toxicol; 2012 Jul; 86(7):1117-22. PubMed ID: 22418596
[TBL] [Abstract][Full Text] [Related]
17. Ultrafine particle-lung interactions: does size matter?
Kreyling WG; Semmler-Behnke M; Möller W
J Aerosol Med; 2006; 19(1):74-83. PubMed ID: 16551218
[TBL] [Abstract][Full Text] [Related]
18. The respiratory microbiome and innate immunity in asthma.
Huang YJ
Curr Opin Pulm Med; 2015 Jan; 21(1):27-32. PubMed ID: 25405668
[TBL] [Abstract][Full Text] [Related]
19. Microbiome and disease in the upper airway.
Lee JT; Kim CM; Ramakrishnan V
Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):1-6. PubMed ID: 30543547
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary exposure to carbonaceous nanomaterials and sperm quality.
Skovmand A; Jacobsen Lauvås A; Christensen P; Vogel U; Sørig Hougaard K; Goericke-Pesch S
Part Fibre Toxicol; 2018 Jan; 15(1):10. PubMed ID: 29386028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
